Photo from Lorenzo Galluzzi/X
Apr 15, 2025, 23:15
Lorenzo Galluzzi: Selective CDK4 inhibition holds promise for breast cancer
Lorenzo Galluzzi, Associate Professor at Fox Chase Cancer Center, shared a post on X:
“Happy to share our recent Cell Research commentary on a recent paper selective CDK4 inhibition in breast cancer. Kudos to to Manuel Beltrán-Visiedo taking the lead on this and thanks to Rebecca M. Shulman for input. Available here.”
Authors: Manuel Beltrán-Visiedo,Rebecca M. Shulman, Lorenzo Galluzzi
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 16, 2025, 17:55
Jul 16, 2025, 17:38
Jul 16, 2025, 17:37
Jul 16, 2025, 17:04
Jul 16, 2025, 16:51
Jul 16, 2025, 16:34
Jul 16, 2025, 16:18
Jul 16, 2025, 16:06